Aclaris Therapeutics (ACRS) Accumulated Depreciation (2014 - 2025)
Aclaris Therapeutics (ACRS) reported Accumulated Depreciation of $4.98 million for Q3 2025, up 6.5% from $4.68 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Accumulated Depreciation (2014 - 2025) Analysis & Trends
At the end of FY2024, Aclaris Therapeutics posted Accumulated Depreciation of $4.81 million, up 15.4% from FY2023.
- Accumulated Depreciation has increased for ten consecutive years, with a five-year compound annual growth rate of 18.4% (FY2019 to FY2024).
- By year, Accumulated Depreciation came in at $4.16 million in FY2023 (+3.1%), $4.04 million in FY2022 (+18.9%), $3.39 million in FY2021 (+29.4%) and $2.62 million in FY2020 (+27.0%).
- Five-year quarterly Accumulated Depreciation spans a low of $2.62 million in Q4 2020 and a high of $5.01 million in Q2 2025.
- Year over year, Accumulated Depreciation has now increased in each of the last 37 quarters, with growth averaging 7.0% over the last eight quarters.
- Across the past five years, year-over-year growth in Accumulated Depreciation ran from 1.7% in Q3 2024 to 29.4% in Q4 2021.
- Per Business Quant data, the three quarters before Q3 2025 came in at $5.01 million (Q2 2025), $4.91 million (Q1 2025) and $4.81 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 5.01 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 4.34 Mn |
| Dec 31, 2023 | 4.16 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.41 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 4.04 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Sep 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | 3.04 Mn |
| Mar 31, 2021 | 2.85 Mn |
| Dec 31, 2020 | 2.62 Mn |
API Access
Aclaris Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();